PZ99 - Thanks man...but yeah it's a fair point that I should...

PZ99 - Thanks man...but yeah it's a fair point that I should state, just cos I do a fair bit of work (there is a lot more I could do if I had the bandwidth trust me, I literally have to hold back my thoughts and topics!)...but it DOESN'T mean we are going to be automatically successful! This is why, as with any investment, you have to imagine what would happen if it doesn't work out for whatever reason.

Not trying to scare anyone.I haven't sold a single share from my core holding....


I respectfully disagree though...once, if, we get certainty and know what is needed, we will be able to sell the story ...it wont be much longer theoretically till we are done once a trial starts...the protocols would be v similar to our P2...repeat that and we are done. This isn't a trial involving thousands...this isn't a trial that will take 4 years to complete. Its a 6 week course, 128 day follow up...and not too many patients...what was n? Around 700 odd for 003...maybe about 500 to 600 for 002 Stage 2 yeah? A lot of the hard work has been done...008 shone a light...002 dosing done...cross over via 006 out of the way.




Mango - yeah I think about this too...but in a perverse way, gee maybe its good that we haven't had a deal yet...imagine the strength of a future deal once we are certain of the way forward, once the data is out....yes I agree we need to sort out funding...I think there will be a few options that are viable. But of course that's my opinion.


Stop-loss - amen, we will keep our eyes open...